NewsRx

Search our medical news database

Cerebral Malaria

TNF-alpha, TGF-beta levels have limited prognostic value in children with cerebral malaria

Published in TB and Outbreaks Week, September 16th, 2003

Levels of pro- and anti-inflammatory cytokines have limited prognostic utility in children with cerebral malaria.

In "a prospective study conducted at the Moi Teaching and Referral Hospital, Eldoret, Kenya," a group of "23 children admitted to the hospital with cerebral (CM) and 10 children with noncerebral malaria (NCM)" were examined "to establish and compare levels of tumor necrosis factor (TNF-alpha) and transforming growth factor (TGF-beta1)".

"Serum and cerebrospinal fluid (CSF) cytokine levels were assayed using ELISA kits. In serum, TGF-beta1 and TNF-alpha decreased over five days after admission to the hospital in both groups of patients...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook